Company · CIK 0001727492
Caligan Partners LP
other
Exchange
—
Entity type
other
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 13F-HRCaligan Partners LP0001420506-26-001809 · 16.3 KBSEC(opens sec.gov)
- 4Insider trades0000902664-26-002852 · 9.1 KBSEC(opens sec.gov)
- 4Insider trades0000902664-26-002641 · 8.8 KBSEC(opens sec.gov)
- 4Insider trades0000902664-26-002578 · 9.8 KBSEC(opens sec.gov)
- SCHEDULE 13GSAB Biotherapeutics, Inc.0001727492-26-000011 · 10.1 KBSEC(opens sec.gov)
- SCHEDULE 13GOpus Genetics, Inc.0001727492-26-000010 · 10.3 KBSEC(opens sec.gov)
- SCHEDULE 13GLB PHARMACEUTICALS INC0001727492-26-000009 · 10.0 KBSEC(opens sec.gov)
- SCHEDULE 13G/AAvalo Therapeutics, Inc.0001727492-26-000008 · 10.1 KBSEC(opens sec.gov)
- 13F-HRCaligan Partners LP0001420506-26-001039 · 16.3 KBSEC(opens sec.gov)
- SCHEDULE 13GSensei Biotherapeutics, Inc.0000902664-26-002472 · 15.8 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
780 THIRD AVENUE 30TH FLOOR
NEW YORK, NY, 10017
mailing
780 THIRD AVENUE 30TH FLOOR
NEW YORK, NY, 10017